Table 1.
Age 66–80 years N (%) |
Age >80 years N (%) |
χ2 p-value |
|
---|---|---|---|
Observation | 403 (11.6) | 300 (26.0) | <0.0001 |
CVP | 30 (0.9) | 23 (2.0) | |
R-CVP | 169 (4.9) | 165 (14.3) | |
CHOP | 296 (8.5) | 73 (6.3) | |
R-CHOP | 2,581 (74.2) | 595 (51.5) |
Note: CVP=cyclophosphamide, vincristine, prednisone; R-CVP=rituximab + CVP; CHOP=cyclophosphamide, doxorubicin, vincristine, prednisone; R-CHOP=rituximab + CHOP
Note: percentages may not add up to 100.0% due to rounding.